Michael F. Neidorff

Michael F. Neidorff

Chairman and Chief Executive Officer

Mr. Neidorff has served as our Chairman, President and Chief Executive Officer since April 2019. From November 2017 to April 2019, he served as our Chairman and Chief Executive Officer. From May 2004 to November 2017, he served as Chairman, President and Chief Executive Officer. From May 1996 to May 2004, he served as President, Chief Executive Officer and as a member of our Board of Directors. Mr. Neidorff previously served as a director of Caleres, Inc.

Brent D. Layton

Brent D. Layton

Executive Vice President, Markets, Products, International, and Chief Business Development Officer

Mr. Layton has served as our Executive Vice President, Markets, Products, International, and Chief Business Development Officer since January 2021. In March 2021, he was appointed to President of U.S. Health plans, Products, and International. From July 2016 to December 2020, he served as Executive Vice President and Chief Business Development Officer. From September 2011 to June 2016, he served as Senior Vice President, Business Development.

Sarah M. London

Sarah M. London

Vice Chairman, Centene Board of Directors

Ms. London has served as Vice Chairman for Centene’s Board of Directors since September 2021. She also has served as President of Health Care Enterprises, and Executive Vice President of Advanced Technology since March 2021. Ms. London previously held the role of Centene’s Senior Vice President of Technology Innovation and Modernization. She has also served as Partner for Optum Ventures, Chief Product Officer for Optum Analytics, and Vice President of Client Services and Operations with Humedica.

Andrew L. Asher

Andrew L. Asher

Executive Vice President, Chief Financial Officer

Mr. Asher has served as our Executive Vice President, Chief Financial Officer since May 2021. He joined Centene in conjunction with the closing of the WellCare acquisition in January 2020 and served as Executive Vice President, Envolve Health and Chief Executive Officer, Envolve Pharmacy Solutions until May 2021. Prior to joining Centene, Mr. Asher served as chief financial officer of WellCare for six years.

Colin A. Toney

Executive Vice President, Mergers and Acquisitions

Before joining Centene, Mr. Toney worked at Allen & Company, advising companies in healthcare, technology, media, and other industries on mergers and acquisitions and capital raising. Mr. Toney executed over 25 closed M&A transactions representing over $30 billion, including working with Centene on the Health Net and Fidelis Care acquisitions. Before joining Allen & Company, Mr. Toney worked in M&A at the investment banking firm Stephens Inc.

Brandy L. Burkhalter

Brandy L. Burkhalter

Executive Vice President, Chief Operating Officer

Ms. Burkhalter has served as our Executive Vice President, Chief Operating Officer since June 2018. From December 2015 to June 2018, she served as Executive Vice President, Internal Audit & Risk Management.

Susan H. Coatar

Susan H. Coatar

Vice President, Chief of Staff

Christopher A. Koster

Christopher A. Koster

Senior Vice President, General Counsel and Secretary

Mr. Koster has served as Senior Vice President, Secretary and General Counsel since February 2020. From February 2017 to February 2020, he served as Senior Vice President, Corporate Services. Prior to joining Centene, Mr. Koster served as Missouri Attorney General for eight years.

Dr. Ken Yamaguchi

Dr. Ken Yamaguchi

Executive Vice President, Chief Medical Officer

Marcela Manjarrez Hawn

Marcela Manjarrez Hawn

Senior Vice President, Chief Communications Officer

Keith H. Williamson

Keith H. Williamson

President, Centene Foundation

Shannon Bagley

Shannon Bagley

Executive Vice President, Chief Administrative Officer

Jennifer L. Gilligan

Jennifer L. Gilligan

Senior Vice President, Finance & Investor Relations

Ms. Gilligan joined Centene Corporation as Senior Vice President, Finance & Investor Relations in April 2020. Prior to joining Centene, Jennifer spent nearly 10 years on Wall Street within Equity Research covering Health Care Services, most recently as a Vice President at BMO Capital Markets.